August 14, 2026

Reviewed by Brian St. Pierre, MS, RD “Is this drug going to steal my job?” That’s the thought many health and fitness coaches had when GLP-1 medications first hit the mass market. Though semaglutide (Ozempic) became available in 2017, it initially felt like a theoretical threat. Prescription rates were still very low; it seemed like